Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 5 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 11976109

    Neutralizing antibodies to ebola virus glycoprotein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2024 · Expires May 2, 2044

    granted
  2. US 11969466

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  3. US 11964010

    Prefusion coronavirus spike proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  4. US 11951159

    Cattle fever tick-infestation vaccines and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  5. US 11951131

    Anti-SLAMF7 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  6. US 11939365

    T cell receptors recognizing mutated P53

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  7. US 11939345

    Physiologically stable fluorophore and performing fluorescence probing

    Government of the United States of America, as represented by the Secretary of Commerce · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  8. US 11939356

    Self-assembling insect ferritin nanoparticles

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  9. US 11938221

    Multivalent nanoparticle-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  10. US 11939297

    Cannabinoid receptor mediating compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  11. US 11938177

    Peptide vaccine formulations and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  12. US 11939377

    Affinity matured CD22-specific monoclonal antibody and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  13. US 11925664

    Intracellular genomic transplant and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  14. US 11926656

    Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  15. US 11918639

    Methods and compositions for inducing protective immunity against filovirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  16. US 11918638

    Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  17. US 11918640

    Methods of preparing anti-human papillomavirus antigen T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  18. US 11904057

    Nanoparticle-hydrogel composite for nucleic acid molecule delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  19. US 11905313

    Recombinant RSV G proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  20. US 11904006

    Poly(diaminosulfide) particle-based vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  21. US 11898166

    In vitro generation of thymic organoid from human pluripotent stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  22. US 11898207

    Methods of isolating neoantigen-specific T cell receptor sequences

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  23. US 11897933

    Anti-KRAS-G12D T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  24. US 11897875

    Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted